In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

Mayo Clin Proc. 2020 Jul;95(7):1553-1556. doi: 10.1016/j.mayocp.2020.05.003. Epub 2020 May 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin Receptor Antagonists* / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Angiotensins
  • Antihypertensive Agents / therapeutic use
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Coronavirus*
  • Humans
  • Inflammation / drug therapy
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensins
  • Antihypertensive Agents